Tumor regrowth and development of keratinocytic neoplasms in patients under smoothened inhibition: in vivo assessment with reflectance confocal microscopy
- 27 October 2016
- journal article
- research article
- Published by Wiley in Skin Research and Technology
- Vol. 23 (3) , 283-288
Abstract
Background: The regrowth of a tumor after complete clinical response and the development of keratinocytic neoplasms while patients are still undergoing continuous vismodegib have stressed the importance of the accurate monitoring to detect recurrences earlier and ensure the best possible outcome.Objective: The objective of this study was to determine the role of reflectance confocal microscopy (RCM) in monitoring the response of locally advanced basal cell carcinoma (laBCC) to vismodegib and to discard secondary resistance.Methods: Seven patients presenting with nine laBCC, were prospectively included and their response to this drug was assessed by means of clinical examination, dermoscopy, and RCM. The study was conducted at the Melanoma Unit in Hospital Clinic of Barcelona, between June 2012 and March 2013.Results: Histologically confirmed lesion 10 mm or larger in diameter for which surgery was contraindicated and radiation therapy was inappropriate. The median patient age was 73 years and the most common histological type was infiltrating BCC. RCM allowed the identification of residual tumor in two lesions and to confirm complete response in the other four cases. Two patients developed new lesions within the tumor bed, they were assessed by RCM showing features of actinic keratosis which were confirmed by histopathology.Conclusion: The use of in vivo RCM allowed the characterization of the dynamic morphologic changes in tumor response helping to better define partial response and to differentiate it from secondary resistance. Another interesting observation was the recognition of a phenomenon characterized by the development of keratinocytic neoplasms within the tumor bed.Keywords
Funding Information
- Federación Española de Enfermedades Raras
This publication has 13 references indexed in Scilit:
- Two Different Scenarios of Squamous Cell Carcinoma Within Advanced Basal Cell CarcinomasJAMA Dermatology, 2014
- Vismodegib as Eye-Sparing Adjuvant Treatment for Orbital Basal Cell CarcinomaJAMA Ophthalmology, 2013
- Ptch1 Overexpression Drives Skin Carcinogenesis and Developmental Defects in K14Ptch MiceJournal of Investigative Dermatology, 2013
- Advanced basal cell carcinoma of the skinCurrent Opinion in Oncology, 2013
- New Onset of Keratoacanthomas After Vismodegib Treatment for Locally Advanced Basal Cell Carcinomas: A Report of 2 CasesJAMA Dermatology, 2013
- Initial Assessment of Tumor Regrowth After Vismodegib in Advanced Basal Cell CarcinomaArchives of Dermatology, 2012
- In Vivo Confocal Microscopy for Diagnosis of Melanoma and Basal Cell Carcinoma Using a Two-Step Method: Analysis of 710 Consecutive Clinically Equivocal CasesJournal of Investigative Dermatology, 2012
- Reflectance confocal microscopy allowsin vivoreal-time noninvasive assessment of the outcome of methyl aminolaevulinate photodynamic therapy of basal cell carcinomaBritish Journal of Dermatology, 2012
- Efficacy and Safety of Vismodegib in Advanced Basal-Cell CarcinomaNew England Journal of Medicine, 2012
- In Vivo Confocal Scanning Laser Microscopy of Human Skin II: Advances in Instrumentation and Comparison With Histology11The authors have declared conflict of interest.Journal of Investigative Dermatology, 1999